In Other News

• Serial Blood Samples Reveal Leukemia’s Evolution Decades Before Diagnosis

• Antibody-Free Blood Test Detects Rheumatic Heart Disease Biomarker

• Liquid Biopsy Expands Insights Into Treatment Response and Tumor Alterations

• Genomic Sequencing Identifies Actionable Findings to Guide Rare Disease Management

• Blood and Spinal Fluid Biomarker May Help Track Early Huntington’s Disease

• Combined Blood Tests Help Clarify Colorectal Cancer Recurrence Risk

• Study Confirms Blood Products Remain Viable After Three Weeks in the Arctic

• New Biomarker Offers Longer Detection Window for Suspected GHB Exposure

• Blood Test Identifies Candidates for Targeted Radiotherapy in Advanced Prostate Cancer

• Liquid Biopsy Captures Gene Activity Patterns in Small-Cell Lung Cancer

• Study Finds Urine Biomarker Score Improves Five-Year Cancer Risk Prediction

• Blood RNA Test May Detect Precursors to Ovarian Cancer

• Microsatellite Instability Test Gains FDA Approval for Immunotherapy Selection

• Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

• Blood-Detected Chromosomal Changes May Refine Colorectal Cancer Risk Assessment

• Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

• AI Tool Automates Variant Curation and Interpretation for Cancer Whole-Genome Sequencing

• Portable Test Detects Zika and Hepatitis C RNA from Whole Blood

• Automated Microbial Identification and Susceptibility System Gains FDA Clearance

• Blood-Based Test May Predict Response Across Rheumatoid Arthritis Drug Classes

• Early Blood Test Patterns Linked to Three-Year Kidney Transplant Outcomes

• Blood Protein Signatures May Predict Brain Vessel Damage and Cognitive Decline

• Flow Cytometry Tests Receive FDA Clearance for B-Cell Lymphoma Diagnosis